Intravenous tPA Delays Door-To-Puncture Time in Acute Ischemic Stroke with Large Vessel Occlusion.
Administration, Intravenous
Aged
Aged, 80 and over
Endovascular Procedures
/ adverse effects
Female
Fibrinolytic Agents
/ administration & dosage
Humans
Ischemic Stroke
/ diagnosis
Male
Middle Aged
Punctures
Retrospective Studies
Thrombectomy
/ adverse effects
Thrombolytic Therapy
/ adverse effects
Time Factors
Time-to-Treatment
Tissue Plasminogen Activator
/ administration & dosage
Treatment Outcome
Acute Ischemic Stroke
Endovascular treatment
Intravenous thrombolysis
Journal
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
03
12
2020
revised:
25
02
2021
accepted:
01
03
2021
pubmed:
18
4
2021
medline:
1
6
2021
entrez:
17
4
2021
Statut:
ppublish
Résumé
Although intravenous thrombolysis (IVT) is recommended among acute ischemic stroke (AIS) patients secondary to large vessel occlusion (LVO) undergoing mechanical thrombectomy (MT), time delays with bridging therapy (IVT prior to MT) and its potential benefit remains unclear. We compared the time delays and clinical outcomes among AIS SECONDARY TO LVO patients treated with bridging therapy or direct MT (dMT) at a comprehensive stroke center (CSC). We performed a retrospective analysis of prospectively collected data of AIS secondary to LVO patients admitted between 2012 and 2017 at a large volume CSC. AIS secondary to LVO patients arriving directly from field to CSC within 4.5 h were included. Demographic characteristics, clinical and radiological data, treatment and procedural information were extracted and analyzed. Among 777 AIS secondary to LVO patients treated with MT, 237 patients (156 dMT, 81 bridging therapy) were included. Mean age was 70.3 year-old, median NIHSS score was 18, and door-to-needle time was 40 min (IQR 31-56 min). The median door-to-puncture (DTP) time was 22 min longer in bridging therapy group in comparison to dMT group, 74 vs 52 min (p<0.001). Additionally, no difference was observed between the groups for successful recanalization or functional independence. At a large volume CSC, bridging therapy (vs. dMT) was observed to have a longer DTP time without any difference in successful recanalization or clinical outcomes.
Identifiants
pubmed: 33865227
pii: S1052-3057(21)00135-X
doi: 10.1016/j.jstrokecerebrovasdis.2021.105732
pii:
doi:
Substances chimiques
Fibrinolytic Agents
0
Tissue Plasminogen Activator
EC 3.4.21.68
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105732Informations de copyright
Copyright © 2021. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None